Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.75% |
| 2 | Healthcare | 9.01% |
| 3 | Technology | 7.75% |
| 4 | Financials | 7.01% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
iShares MSCI ACWI ETF
ACWI
$33.4B
| $1.85M | ﹤0.01% |
25,086
+21,724
| +646% | +$1.52M |
|
2552
CALL
CRISPR Therapeutics
CRSP
$5.74B
| $1.84M | ﹤0.01% |
+25,000
| New | +$1.46M |
|
2553
KORU Medical Systems
KRMD
$148M
| $1.82M | ﹤0.01% |
202,827
-62,337
| -24% | -$630K |
|
2554
PUT
Teleflex
TFX
$5.84B
| $1.82M | ﹤0.01% |
5,000
+2,000
| +67% | +$691K |
|
|
TVRD
2555
Tvardi Therapeutics
TVRD
$24M
| $1.81M | ﹤0.01% |
+2,949
| New | +$1.63M |
|
|
WBA
2556
PUT
DELISTED
Walgreens Boots Alliance
WBA
| $1.81M | ﹤0.01% |
42,700
+25,100
| +143% | +$1.07M |
|
2557
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $1.81M | ﹤0.01% |
7,003
+4,674
| +201% | +$1.15M |
|
2558
Bain Capital Specialty
BCSF
$772M
| $1.8M | ﹤0.01% |
162,916
+69,743
| +75% | +$721K |
|
2559
Cathay General Bancorp
CATY
$4.14B
| $1.8M | ﹤0.01% |
68,616
-114,032
| -62% | -$2.91M |
|
2560
CALL
Zymeworks
ZYME
$2.07B
| $1.8M | ﹤0.01% |
+50,000
| New | +$1.84M |
|
2561
Packaging Corp of America
PKG
$21.7B
| $1.79M | ﹤0.01% |
17,966
-10,983
| -38% | -$1.04M |
|
2562
Best Buy
BBY
$17.6B
| $1.79M | ﹤0.01% |
20,509
-147,603
| -88% | -$11.2M |
|
2563
CALL
Penumbra
PEN
$12.6B
| $1.79M | ﹤0.01% |
10,000
-25,000
| -71% | -$4.34M |
|
|
ONEM
2564
DELISTED
1Life Healthcare
ONEM
| $1.79M | ﹤0.01% |
49,235
+29,875
| +154% | +$841K |
|
2565
Applied Optoelectronics
AAOI
$9.62B
| $1.79M | ﹤0.01% |
164,328
-373,261
| -69% | -$3.42M |
|
2566
News Corp Class A
NWSA
$16.8B
| $1.78M | ﹤0.01% |
150,523
-30,114
| -17% | -$322K |
|
|
THBRU
2567
DELISTED
Thunder Bridge Acquisition II, Ltd. Units
THBRU
| $1.78M | ﹤0.01% |
170,000
-250,000
| -60% | -$2.61M |
|
2568
Capital Southwest
CSWC
$1.62B
| $1.78M | ﹤0.01% |
132,344
-159,439
| -55% | -$2.06M |
|
|
CIICW
2569
CALL
DELISTED
CIIG Merger Corp. Warrants
CIICW
| $1.78M | ﹤0.01% |
+180,000
| New | +$121K |
|
|
CHS
2570
DELISTED
Chicos FAS, Inc.
CHS
| $1.77M | ﹤0.01% |
1,286,497
+1,221,187
| +1,870% | +$1.66M |
|
2571
IPG Photonics
IPGP
$3.29B
| $1.77M | ﹤0.01% |
11,059
-29,233
| -73% | -$4.16M |
|
2572
Park Hotels & Resorts
PK
$3.16B
| $1.77M | ﹤0.01% |
179,032
+130,981
| +273% | +$1.22M |
|
2573
Enpro
NPO
$6.53B
| $1.77M | ﹤0.01% |
35,859
-3,285
| -8% | -$145K |
|
2574
PUT
iShares MSCI Taiwan ETF
EWT
$11.8B
| $1.77M | ﹤0.01% |
+43,900
| New | +$1.63M |
|
2575
Genpact
G
$6.31B
| $1.77M | ﹤0.01% |
48,366
+35,984
| +291% | +$1.22M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $10.9B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.